The Radiosurgery Society® (RSS) is committed to research initiatives and programs designed to advance the field of stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT) and advancing therapies, promote training and career development, and provide safe, high-quality, and effective patient care.
In collaboration with the American College of Radiation Oncology (ACRO), the RSS offers the Distinction in Stereotactic Radiotherapy accreditation program. The program was designed by professional peers with extensive experience treating patients with SRS/SBRT, with the aim to identify standards indicative of a quality practice in the field of SRS/SBRT.
The RSS offers multiple avenues for sharing clinical trial concepts, protocol development and research collaborations in the form of in-person Protocol Development Committee (PDC) meetings, workshops and a Consensus Guidelines for Clinical Trial Design platform. Click here to view the current list of Consensus Guidelines for Clinical Trial Design proposals.
The Radiosurgery Society® (RSS) Mentorship and Career Pathways Program brings together experts (mentors) who provide guidance and career development to residents, fellows and trainees (mentees) who are navigating residency/training and career options in the fields of SRS/SBRT and advancing therapies. This unique program not only provides optimal matching of mentors/mentees using a sophisticated algorithm but provides numerous resources to cultivate that connection. This is a virtual program connecting residents/trainees and faculty based on their responses from our online application.
The RSSearch® Patient Registry is the largest SRS/SBRT patient registry managed by a non-profit medical society. The registry was established in 2005 with the goal of standardizing the collection of screening, treatment and outcomes data from patients treated with SRS/SBRT. RSSearch includes over 30,000 enrolled patients from 40+ centers worldwide and has resulted in numerous publications on topics including intra and extracranial applications.